Metro Hospital, Faridabad - Platelet Rich Plasma (PRP) Therapy in Osteoarthritis of Knee.
  • Emergency
  • Email
  • Video Tour
  • Find a Doctor
  • eBook

News

Platelet Rich Plasma (PRP) Therapy in Osteoarthritis of Knee.

Platelet Rich Plasma (PRP) Therapy in Osteoarthritis of Knee.

Osteoarthritis of knees is a disabling condition with gradual increment of pain and deformity for which patients eventfully need knee replacement surgery. Though age is a major risk factor for osteoarthritis of the knee, young people can get it, too. Osteoarthritis of the knee can also result from injury or infection or even from being overweight.  

However, if patient present early during the course of their problem there are therapies which may retard the progression of disease. One of which is PRP therapy. PRP injections aim to promote cartilage repair thus delaying progression of osteoarthritis. PRP therapy works in early knee osteoarthritis by slowing the progression of arthritis by delivering a high concentration of growth factors which mediate healing and remodeling thus improving clinical outcome. 

 

Dr. Sujoy Bhattacharjee, Director Knee and Joint replacement said that platelet rich plasma, is a non-operative solution for conditions such as early arthritis and tendonitis. Utilizing the body’s natural healing process, PRP therapy is a concentration of platelets that are injected into the damaged ligaments, tendons, and joints to promote tissue repair and accelerate healing. 

 

PRP Injection Therapy is a cost-effective treatment in early arthritis and chronic tendinitis not being relieved by other methods. It is designed to rebuild cartilage and reduce inflammation. This therapy is a boon for patients presenting with early Osteoarthritis.   

 

Dr. Seema Bansal, Director Admin said “I am glad that all new modalities of treatment are available in the hospital for the benefit of the patient. She added that kind of quality work orthopedics deptt is doing under guidance of Dr. Sujoy Bhattacharjee is commendable.” 

BACK TO: ALL TALKS